Patent · US Active

Identification of inhibitors of TcpC and TIR NADase activity

US12247246B2 · kind B2 · utility

0Cited by
14References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2022
Grant dateMar 11, 2025
Priority date
Expiry dateDec 23, 2042

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds useful as inhibitors of TIR NADase activity, compositions thereof, and methods of using the same. The present invention is useful for inhibition of TIR-domain NADase activity and/or treating microbial infection and/or modulating microbial physiology.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.